rs14224
Variant names:
Variant summary
Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_000301.5(PLG):c.771T>C(p.Cys257Cys) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.424 in 1,600,012 control chromosomes in the GnomAD database, including 145,900 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.45 ( 15487 hom., cov: 32)
Exomes 𝑓: 0.42 ( 130413 hom. )
Consequence
PLG
NM_000301.5 synonymous
NM_000301.5 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.334
Publications
30 publications found
Genes affected
PLG (HGNC:9071): (plasminogen) The plasminogen protein encoded by this gene is a serine protease that circulates in blood plasma as an inactive zymogen and is converted to the active protease, plasmin, by several plasminogen activators such as tissue plasminogen activator (tPA), urokinase plasminogen activator (uPA), kallikrein, and factor XII (Hageman factor). The conversion of plasminogen to plasmin involves the cleavage of the peptide bond between Arg-561 and Val-562. Plasmin cleavage also releases the angiostatin protein which inhibits angiogenesis. Plasmin degrades many blood plasma proteins, including fibrin-containing blood clots. As a serine protease, plasmin cleaves many products in addition to fibrin such as fibronectin, thrombospondin, laminin, and von Willebrand factor. Plasmin is inactivated by proteins such as alpha-2-macroglobulin and alpha-2-antiplasmin in addition to inhibitors of the various plasminogen activators. Plasminogen also interacts with plasminogen receptors which results in the retention of plasmin on cell surfaces and in plasmin-induced cell signaling. The localization of plasminogen on cell surfaces plays a role in the degradation of extracellular matrices, cell migration, inflamation, wound healing, oncogenesis, metastasis, myogenesis, muscle regeneration, neurite outgrowth, and fibrinolysis. This protein may also play a role in acute respiratory distress syndrome (ARDS) which, in part, is caused by enhanced clot formation and the suppression of fibrinolysis. Compared to other mammals, the cluster of plasminogen-like genes to which this gene belongs has been rearranged in catarrhine primates. [provided by RefSeq, May 2020]
PLG Gene-Disease associations (from GenCC):
- hypoplasminogenemiaInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, ClinGen, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
- angioedema, hereditary, 4Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BP6
Variant 6-160716747-T-C is Benign according to our data. Variant chr6-160716747-T-C is described in ClinVar as [Benign]. Clinvar id is 1175116.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.334 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.524 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PLG | ENST00000308192.14 | c.771T>C | p.Cys257Cys | synonymous_variant | Exon 7 of 19 | 1 | NM_000301.5 | ENSP00000308938.9 | ||
PLG | ENST00000418964.2 | c.822T>C | p.Cys274Cys | synonymous_variant | Exon 7 of 19 | 4 | ENSP00000389424.2 | |||
PLG | ENST00000706906.1 | n.771T>C | non_coding_transcript_exon_variant | Exon 7 of 19 | ENSP00000516618.1 | |||||
PLG | ENST00000297289.9 | c.50-5661T>C | intron_variant | Intron 1 of 10 | 5 | ENSP00000516619.1 |
Frequencies
GnomAD3 genomes AF: 0.447 AC: 67863AN: 151930Hom.: 15484 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
67863
AN:
151930
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.414 AC: 104031AN: 251182 AF XY: 0.418 show subpopulations
GnomAD2 exomes
AF:
AC:
104031
AN:
251182
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.422 AC: 610359AN: 1447964Hom.: 130413 Cov.: 30 AF XY: 0.424 AC XY: 305521AN XY: 721148 show subpopulations
GnomAD4 exome
AF:
AC:
610359
AN:
1447964
Hom.:
Cov.:
30
AF XY:
AC XY:
305521
AN XY:
721148
show subpopulations
African (AFR)
AF:
AC:
17520
AN:
33174
American (AMR)
AF:
AC:
14229
AN:
44712
Ashkenazi Jewish (ASJ)
AF:
AC:
12913
AN:
26038
East Asian (EAS)
AF:
AC:
17436
AN:
39630
South Asian (SAS)
AF:
AC:
39253
AN:
86004
European-Finnish (FIN)
AF:
AC:
18485
AN:
53410
Middle Eastern (MID)
AF:
AC:
2860
AN:
5736
European-Non Finnish (NFE)
AF:
AC:
461303
AN:
1099310
Other (OTH)
AF:
AC:
26360
AN:
59950
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.471
Heterozygous variant carriers
0
16881
33762
50643
67524
84405
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.447 AC: 67907AN: 152048Hom.: 15487 Cov.: 32 AF XY: 0.443 AC XY: 32894AN XY: 74328 show subpopulations
GnomAD4 genome
AF:
AC:
67907
AN:
152048
Hom.:
Cov.:
32
AF XY:
AC XY:
32894
AN XY:
74328
show subpopulations
African (AFR)
AF:
AC:
21976
AN:
41478
American (AMR)
AF:
AC:
5738
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
AC:
1721
AN:
3472
East Asian (EAS)
AF:
AC:
2349
AN:
5162
South Asian (SAS)
AF:
AC:
2143
AN:
4810
European-Finnish (FIN)
AF:
AC:
3602
AN:
10578
Middle Eastern (MID)
AF:
AC:
171
AN:
294
European-Non Finnish (NFE)
AF:
AC:
28799
AN:
67946
Other (OTH)
AF:
AC:
948
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1903
3805
5708
7610
9513
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1459
AN:
3476
ClinVar
Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:2
-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
not provided Benign:2
Jun 09, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Angioedema, hereditary, 4 Benign:1
Oct 25, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Plasminogen deficiency, type I Benign:1
Oct 25, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.